Free Intellia Therapeutics Inc. (NTLA) Technical Analysis Signals
Intellia Therapeutics Inc. (NTLA) signal with technical analysis on 03 Dec
DEMA 1DEMA 2DEMA 3EMA Price Cross 1EMA Price Cross 2EMA Price Cross 4KAMA 1EMA Crossover 1WMA Crossover 1TEMA Price 1TEMA Price 2TEMA Price 3SAR CrossoverMOM Crossover 1ROC Threshold 1ROCR Threshold 1ROCR Threshold 2WILLR Exit OversoldBOP Smoothed ThresholdStochastic RSI SignalMoney Flow IndexChaikin AD CrossoverDaily Pivot Point 1CMO Divergence 1
Long Line Candle
Overall Strategy:
Buy Signals: 24
Sell Signals: 2
Neutral Signals: 73
Result: This strategy leads to a Buy position.
Disclaimer! Please exercise caution and thorough consideration before making any financial decisions. It's important to note that our signals are based solely on daily price changes and do not take into account external factors such as news, market sentiment, or company developments. We strongly recommend considering all relevant factors and conducting your own research.
Useful Tips: To make the most informed decisions about your Intellia Therapeutics Inc. (NTLA) investments, we highly recommend visiting the "magicalprediction" AI models signals website. They provide free signals, and if one aligns with ours, it is likely to be a reliable indicator, as we have observed over time.
Result: Looking at the technical analysis for Intellia Therapeutics Inc. (NTLA) on , there seems to be a tendency toward a buy signal based on historical data and analysis. However, it's important to remember that these signals are not guarantees, and any investment decision should be made carefully. Consider the overall market conditions and how your choices align with your specific investment goals.
Based on the above signals, we recommend the following strategies:
Intellia Therapeutics Inc. (NTLA) trading strategy for those in buy positions (long positions): If you are currently in a buy (long) position, holding your position may be a good strategy according to our signals. However, always exercise caution and monitor market developments closely.
Intellia Therapeutics Inc. (NTLA) trading strategy for those in sell positions (short positions): If you are currently in a sell (short) position, it is recommended to choose the optimal time to exit based on our signal combination. If you have a higher risk tolerance, consider waiting for market movements in the coming days.
For new positions: If you are not currently in the market or are considering switching to a buy (long) position, it’s advisable to consider the projected price range. This range represents a potential upside of 8%, determined by the highest predicted price. However, before deciding to enter a buy position, be cautious and conduct thorough research to ensure it aligns with your risk tolerance and investment goals.
In all your trading endeavors, implementing a well-defined stop-loss strategy is crucial for managing potential downside risks effectively.
Useful Tip 2: For those interested in long-term forecasting, we suggest utilizing the "predict-price" website, which offers both short-term and long-term predictions for free. This can help you make more informed decisions regarding your **Intellia Therapeutics Inc. (NTLA)** holdings.
Intellia Therapeutics Inc. (NTLA) Price Analysis and Resistance Levels:
Given our current long position in Intellia Therapeutics Inc. (NTLA), analyzing key resistance levels is crucial to better understand its price movement. These levels are important benchmarks for our strategy, and we will explore multiple scenarios to provide a comprehensive outlook.First resistance level (9.269): The primary hurdle we face is the 9.269 price level. If the current trend remains unchanged, Intellia Therapeutics Inc. (NTLA) could break above this level, signaling its strength and potential for further growth.
Second resistance level (9.785): If the upward trend continues with significant strength, we may see Intellia Therapeutics Inc. (NTLA) cross the second resistance level at 9.785, indicating a major upside move and a promising direction for our position.
Third resistance level (10.68): For a more comprehensive analysis, consider a scenario where Intellia Therapeutics Inc. (NTLA) not only breaks the second resistance level but holds its price above this mark. If this trend continues in the coming days, Intellia Therapeutics Inc. (NTLA) could potentially reach the third resistance level of 10.68.
It's essential to closely monitor these resistance levels and consider them in the broader context of market trends and indicators. To make informed decisions when trading Intellia Therapeutics Inc. (NTLA), stay alert and continually analyze the market. By focusing on these resistance levels and considering broader market dynamics, you can make smarter trading decisions and adapt to this dynamic market.
Intellia Therapeutics Inc. (NTLA) technical analysis chart
Intellia Therapeutics Inc. (NTLA) support and resistance levels
| Name | Level1 | Level2 | Level3 | Level4 | Level5 |
|---|---|---|---|---|---|
| Resistance | 9.269 | 9.785 | 10.68 | -- | -- |
| Support | 7.21 | 5.9 | -- | -- | -- |
Intellia Therapeutics Inc. (NTLA) signals list for 03 Dec
| Overall Signals |
|---|
Intellia Therapeutics Inc. (NTLA) candlestick patterns on 03 Dec
Intellia Therapeutics Inc. (NTLA) technical analysis over the past days
| # | Date | Overal Signals | ALL Signals |
|---|---|---|---|
| 1 | 03 Dec | B | DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 4EMA Crossover 1WMA Crossover 1MIDPOINT Slope 1MIDPOINT Slope 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1TRIX Crossover 2WILLR Exit OversoldBOP Smoothed ThresholdSTOCH Normal Zone CrossDaily Pivot Point 1CMO Divergence 1 |
| 2 | 02 Dec | S | DEMA 1DEMA 2DEMA 3EMA Price Cross 1EMA Price Cross 4KAMA 4EMA Crossover 5T3 Slope 1TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3MOM Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1ROCR Threshold 2WILLR Exit OverboughtBOP Smoothed ThresholdStochastic RSI SignalChaikin AD CrossoverGolden/Death Cross (EMA50/EMA200)Daily Pivot Point 1 |
| 3 | 01 Dec | S | DEMA 1DEMA 2DEMA 3EMA Price Cross 1KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3AROONOSC 1AROONOSC 3MOM Crossover 1PLUS_DI Threshold 1ROC Threshold 1ROCR Threshold 2WILLR Exit OversoldBOP Smoothed ThresholdDaily Pivot Point 1CMO Divergence 1 |
| 4 | 28 Nov | B | DEMA 1DEMA 2DEMA 3KAMA 4EMA Crossover 1WMA Crossover 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1BOP Smoothed ThresholdMoney Flow IndexHammer / Hanging ManADXR with DI+/DI- |
| 5 | 26 Nov | N | DEMA 1DEMA 2DEMA 3EMA Price Cross 4KAMA 4TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldTRIX Crossover 1BOP Smoothed ThresholdMACD Crossover 2Percentage Price OscillatorChaikin AD CrossoverHammer / Hanging ManDaily Pivot Point 1CMO Divergence 1CMO Divergence 2 |
| 6 | 25 Nov | B | DEMA 1DEMA 2KAMA 2KAMA 4WMA Crossover 1TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdMoney Flow IndexCMO Divergence 1 |
| 7 | 24 Nov | N | DEMA 1DEMA 2KAMA 2KAMA 4MIDPOINT Slope 4TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OverboughtBOP Smoothed ThresholdStochastic RSI SignalUltimate OscillatorCMO Divergence 1 |
| 8 | 21 Nov | N | DEMA 2KAMA 2KAMA 3KAMA 4MIDPOINT Slope 3TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDonchian ChannelDaily Pivot Point 1CMO Divergence 1 |
| 9 | 20 Nov | S | DEMA 2KAMA 2KAMA 3KAMA 4TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdEngulfing PatternDaily Pivot Point 1CMO Divergence 1 |
| 10 | 19 Nov | S | DEMA 2KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ADXR with DI+/DI-CMO Divergence 1 |
| 11 | 18 Nov | S | DEMA 2KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3CCI Crossover 1CMO Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdUltimate OscillatorCMO Divergence 1 |
| 12 | 17 Nov | S | DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3CCI Crossover 3PLUS_DI Threshold 1Money Flow Index |
| 13 | 14 Nov | N | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2MIDPOINT Slope 4TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3AROONOSC 1AROONOSC 3PLUS_DI Threshold 1BOP Smoothed ThresholdSTOCH Normal Zone CrossDonchian ChannelDaily Pivot Point 1CMO Divergence 1 |
| 14 | 13 Nov | S | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1WILLR Exit OversoldBOP Smoothed ThresholdDaily Pivot Point 1CMO Divergence 1 |
| 15 | 12 Nov | S | KAMA 1KAMA 3KAMA 4MIDPOINT Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1BOP Smoothed ThresholdMACD Crossover 1Stochastic RSI Signal |
| 16 | 11 Nov | N | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4TEMA Price 2TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3CCI Crossover 2PLUS_DI Threshold 1BOP Smoothed ThresholdMoney Flow IndexDEMA with ATR 3 |
| 17 | 10 Nov | S | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4EMA Crossover 4MIDPOINT Slope 3MIDPOINT Slope 4TEMA Price 1TEMA Price 3TRIMA Slope 2TRIMA Slope 3AROONOSC 1AROONOSC 3CMO Crossover 1PLUS_DI Threshold 1ROCR Threshold 1MACD Crossover 1DEMA with ATR 3Volume SpikeADXR with DI+/DI-Donchian ChannelCMO Divergence 1 |
| 18 | 07 Nov | S | EMA Price Cross 4KAMA 3KAMA 4WMA Crossover 1TEMA Price 2TRIMA Slope 2TRIMA Slope 3BOP Smoothed ThresholdStochastic RSI SignalDaily Pivot Point 1 |
| 19 | 06 Nov | S | EMA Price Cross 4KAMA 3KAMA 4WMA Crossover 1TEMA Price 2TRIMA Slope 2TRIMA Slope 3CCI Crossover 2ROCR Threshold 1RSI Exit OversoldBOP Smoothed ThresholdMACD Crossover 1Ultimate OscillatorDaily Pivot Point 1CMO Divergence 1 |
| 20 | 05 Nov | B | DEMA 3KAMA 3KAMA 4WMA Crossover 4T3 Slope 2TRIMA Slope 2TRIMA Slope 3BOP Smoothed ThresholdStochastic RSI SignalDaily Pivot Point 1CMO Divergence 1 |
| 21 | 04 Nov | S | DEMA 3KAMA 3KAMA 4T3 Slope 2TEMA Price 2TRIMA Slope 2TRIMA Slope 3CCI Crossover 1CMO Divergence 1 |
| 22 | 03 Nov | S | DEMA 3KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2CCI Crossover 3BBANDS Breakout 2Stochastic RSI SignalMoney Flow IndexDEMA with ATR 3Ichimoku 1Schaff Trend Cycle |
| 23 | 31 Oct | S | DEMA 2DEMA 3KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2AROONOSC 4CMO Crossover 1DEMA with ATR 2DEMA with ATR 3ADXR with DI+/DI-Donchian ChannelCMO Divergence 1 |
| 24 | 30 Oct | S | DEMA 2DEMA 3KAMA 2KAMA 3KAMA 4EMA Crossover 3MIDPOINT Slope 1MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2BOP Smoothed ThresholdDEMA with ATR 2DEMA with ATR 3Volume SpikeADXR with DI+/DI-Donchian ChannelDaily Pivot Point 1CMO Divergence 1Coppock Curve |
| 25 | 29 Oct | S | DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1BOP Smoothed ThresholdDEMA with ATR 1DEMA with ATR 2DEMA with ATR 3Volume SpikeADXR with DI+/DI-CMO Divergence 1 |
| 26 | 28 Oct | S | DEMA 1DEMA 2DEMA 3EMA Price Cross 1EMA Price Cross 2EMA Price Cross 3KAMA 1KAMA 2KAMA 3KAMA 4EMA Crossover 1EMA Crossover 2WMA Crossover 2WMA Crossover 3MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1SAR CrossoverAROONOSC 1AROONOSC 2AROONOSC 3MOM Crossover 1MOM Crossover 2ADX +DI/-DI CrossoverPLUS_DI Threshold 2ROC Threshold 1ROC Threshold 2ROCR Threshold 1ROCR Threshold 2ROCR Threshold 3ROCR Threshold 4WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdBBANDS Breakout 1Volume SpikeADXR with DI+/DI-Keltner Channel 1Donchian ChannelIchimoku 2Ichimoku 3Rolling VWAPVortex IndicatorElder's Force IndexCMO Divergence 1 |
| 27 | 27 Oct | S | DEMA 2DEMA 3EMA Price Cross 4MIDPOINT Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 1BOP Smoothed ThresholdOBV CrossoverChaikin AD CrossoverChaikin ADOSC Zero CrossCMO Divergence 2 |
| 28 | 24 Oct | S | EMA Price Cross 1EMA Price Cross 4KAMA 2KAMA 3KAMA 4WMA Crossover 1MIDPOINT Slope 1TEMA Price 3TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1ROCR Threshold 2BOP Smoothed ThresholdMACD Crossover 2Chaikin AD CrossoverADXR with DI+/DI- |
| 29 | 23 Oct | B | DEMA 1DEMA 2DEMA 3EMA Price Cross 1EMA Price Cross 4TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3CCI Crossover 1CCI Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROCR Threshold 1RSI Exit OverboughtTRIX Crossover 2BOP Smoothed ThresholdSTOCH Normal Zone CrossChaikin AD CrossoverADXR with DI+/DI-Daily Pivot Point 1CMO Divergence 1 |
| 30 | 22 Oct | S | KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 3TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldMACD Crossover 1Stochastic RSI SignalADXR with DI+/DI- |
Users forecasts for Intellia Therapeutics Inc. (NTLA)
What is your prediction?
In this section, you can easily predict without user registration. See also other users predictions.